Howard Hughes Medical Institute, Harvard University and Harvard Medical School, Cambridge, Massachusetts 02138, USA.
Genes Dev. 2010 Oct 15;24(20):2239-63. doi: 10.1101/gad.1963910.
The generation of induced pluripotent stem cells (iPSCs) from somatic cells demonstrated that adult mammalian cells can be reprogrammed to a pluripotent state by the enforced expression of a few embryonic transcription factors. This discovery has raised fundamental questions about the mechanisms by which transcription factors influence the epigenetic conformation and differentiation potential of cells during reprogramming and normal development. In addition, iPSC technology has provided researchers with a unique tool to derive disease-specific stem cells for the study and possible treatment of degenerative disorders with autologous cells. In this review, we summarize the progress that has been made in the iPSC field over the last 4 years, with an emphasis on understanding the mechanisms of cellular reprogramming and its potential applications in cell therapy.
诱导多能干细胞(iPSC)的生成表明,通过强制表达少数几个胚胎转录因子,成年哺乳动物细胞可以被重编程为多能状态。这一发现引发了关于转录因子在重编程和正常发育过程中如何影响细胞的表观遗传构象和分化潜能的基本问题。此外,iPSC 技术为研究人员提供了一种独特的工具,即用自体细胞衍生出特定疾病的干细胞,用于治疗退行性疾病。在这篇综述中,我们总结了过去 4 年中 iPSC 领域的进展,重点是理解细胞重编程的机制及其在细胞治疗中的潜在应用。